FDA Inspection 996651 — Teva Canada Limited

Teva Canada Limited — FEI 3002807750

The FDA completed an inspection of Teva Canada Limited on Nov 11, 2016 in Stouffville. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 11, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stouffville (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.